These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9407426)

  • 21. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.
    Ji S; Liu M; Chen J; Yin L; Sha G; Chen H; Liu Z; Li L
    Clin Transplant; 2004 Oct; 18(5):536-40. PubMed ID: 15344956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New strategies for the treatment of chronic rejection.
    Hoerbelt R; Muniappan A; Madsen JC; Allan JS
    Curr Opin Investig Drugs; 2004 May; 5(5):489-98. PubMed ID: 15202721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic renal allograft dysfunction.
    Chapman JR; O'Connell PJ; Nankivell BJ
    J Am Soc Nephrol; 2005 Oct; 16(10):3015-26. PubMed ID: 16120819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic allograft nephropathy: current concepts and future directions.
    Nankivell BJ; Chapman JR
    Transplantation; 2006 Mar; 81(5):643-54. PubMed ID: 16534463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical predictors of renal allograft histopathology: a comparative study of single-lesion histology versus a composite, quantitative scoring system.
    Yilmaz S; McLaughlin K; Paavonen T; Taskinen E; Monroy M; Aavik E; Vamvakopoulos J; Häyry P
    Transplantation; 2007 Mar; 83(6):671-6. PubMed ID: 17414693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute rejection in non-compliant renal allograft recipients: a distinct morphology.
    Lerut E; Kuypers DR; Verbeken E; Cleutjens J; Vlaminck H; Vanrenterghem Y; Van Damme B
    Clin Transplant; 2007; 21(3):344-51. PubMed ID: 17488383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
    Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
    Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive drug therapy and subclinical acute renal allograft rejection: impact and effect.
    Kuypers DR
    Transplantation; 2008 Apr; 85(7 Suppl):S25-30. PubMed ID: 18401259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor (HGF) as a rapid diagnostic marker and its potential in the prevention of acute renal rejection.
    Yoshimura R; Watanabe Y; Kasai S; Wada S; Ohyama A; Hase T; Nakatani T; Chargui J; Touraine JL; Nakamura T
    Transpl Int; 2002 Apr; 15(4):156-62. PubMed ID: 11976737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of electron microscopy in the diagnosis of chronic renal allograft rejection.
    Ivanyi B; Kemeny E; Szederkenyi E; Marofka F; Szenohradszky P
    Mod Pathol; 2001 Dec; 14(12):1200-8. PubMed ID: 11743041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of renal allograft fibrosis.
    Waller JR; Nicholson ML
    Br J Surg; 2001 Nov; 88(11):1429-41. PubMed ID: 11683737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction.
    Kahan BD
    Transplantation; 2001 Jun; 71(11 Suppl):SS52-7. PubMed ID: 11583490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study.
    Gutiérrez P; Marrero D; Hernández D; Vivancos S; Pérez-Tamajón L; Rodríguez de Vera JM; Alarcó A; González-Posada JM
    Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [From acute to chronic rejection after kidney transplantation].
    Arns W; Weber M
    Med Klin (Munich); 2002 Oct; 97(10):609-13. PubMed ID: 12386794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, timing, and risk factors for acute and chronic rejection.
    Neuberger J
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S30-6. PubMed ID: 10431015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.